Story perspectives

Chile Secures 8.65 Million Influenza Vaccine Doses from Sinovac

1/13/2026

41 5

Summary

Story summary

The Chilean government contracted Sinovac Biotech, the Chinese biopharmaceutical firm, to supply 8.65 million doses of the influenza vaccine for US$14.7 million in Chile's nationwide immunization program.
The vaccine uses inactivated virus technology with minimal side effects.
Doses are expected to arrive in January, with the campaign beginning in March to address the H3N2 influenza A strain spreading in Europe and Asia.
The campaign aims to protect high-risk groups.

1 of 1

Story summary

The Chilean government contracted Sinovac Biotech, the Chinese biopharmaceutical firm, to supply 8.65 million doses of the influenza vaccine for US$14.7 million in Chile's nationwide immunization program.
The vaccine uses inactivated virus technology with minimal side effects.
Doses are expected to arrive in January, with the campaign beginning in March to address the H3N2 influenza A strain spreading in Europe and Asia.
The campaign aims to protect high-risk groups.